LINC01228
gene geneOn this page
Also known as lincRNA-DYNLRB2-2
Summary
LINC01228 (long intergenic non-protein coding RNA 1228, HGNC:49681) is a long non-coding RNA gene on chromosome 16q23.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49681 |
| Approved symbol | LINC01228 |
| Name | long intergenic non-protein coding RNA 1228 |
| Location | 16q23.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | lincRNA-DYNLRB2-2 |
| Ensembl gene | ENSG00000261082 |
| Ensembl biotype | lncRNA |
| Entrez | 104266962 |
| RNAcentral | URS00021231F7 — lncRNA, 838 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000567966, ENST00000766963
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000567966 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004126105 | 79797826 | 79798509 |
| ENSE00004126107 | 79826988 | 79827185 |
Expression profiles
Bgee: expression breadth broad, 86 present calls, max score 80.30.
Top tissues by expression
86 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.30 | silver quality |
| ganglionic eminence | UBERON:0004023 | 61.79 | gold quality |
| cortical plate | UBERON:0005343 | 61.54 | gold quality |
| monocyte | CL:0000576 | 59.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 57.36 | gold quality |
| gall bladder | UBERON:0002110 | 56.95 | gold quality |
| left uterine tube | UBERON:0001303 | 56.09 | gold quality |
| prefrontal cortex | UBERON:0000451 | 53.49 | gold quality |
| placenta | UBERON:0001987 | 53.43 | gold quality |
| urinary bladder | UBERON:0001255 | 52.37 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 52.06 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 51.51 | gold quality |
| bone marrow | UBERON:0002371 | 51.04 | silver quality |
| blood | UBERON:0000178 | 50.06 | silver quality |
| liver | UBERON:0002107 | 49.97 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 49.64 | gold quality |
| right lobe of liver | UBERON:0001114 | 49.25 | silver quality |
| endometrium | UBERON:0001295 | 48.83 | gold quality |
| muscle of leg | UBERON:0001383 | 48.59 | gold quality |
| gastrocnemius | UBERON:0001388 | 47.91 | gold quality |
| body of uterus | UBERON:0009853 | 47.44 | gold quality |
| vagina | UBERON:0000996 | 47.36 | gold quality |
| primary visual cortex | UBERON:0002436 | 46.68 | silver quality |
| endocervix | UBERON:0000458 | 46.14 | gold quality |
| myometrium | UBERON:0001296 | 45.32 | gold quality |
| heart left ventricle | UBERON:0002084 | 44.94 | gold quality |
| islet of Langerhans | UBERON:0000006 | 44.89 | silver quality |
| tonsil | UBERON:0002372 | 44.49 | gold quality |
| right adrenal gland | UBERON:0001233 | 44.08 | gold quality |
| putamen | UBERON:0001874 | 44.03 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Oxidized-LDL significantly induces lincRNA-DYNLRB2-2 expression, which promotes ABCA1-mediated cholesterol efflux and inhibits inflammation through GPR119 in THP-1 cells. (PMID:24493833)
- Results show that LincRNA DYN-LRB2-2 upregulates cholesterol efflux by decreasing TLR2 expression in macrophages. (PMID:28815701)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.